Affymetrix is headquartered in Santa Clara Calif

It’s a shame, too, as he’s quite the nifty little player.Polanco, on the other hand, seems like a much more realistic possibility. He’s a 3-4 win player who’s going to be earning something like $7 million a year, so there’s no need to worry about overpaying for wins, and he could theoretically be an excellent addition to this Mariners team.He’s been above average defensively by UZR for six of the last seven seasons, and he’s just about a league average hitter. However, he’d only be a small upgrade in value over Lopez, but he’d cost about $6 million more so it’d really come down to what the return is in any Lopez deal.If it were, say, the Jose Lopez, Mark Lowe, and Jason Vargas to Chicago for John Danks deal that Dave Cameron proposed , we’d be trading about $4 million in 2010 salaries and five WAR for about $3 million in 2010 salaries and three WAR.Then, if we sign Polanco for say a two-year/$14 million deal, we end up with $10 million in 2010 salaries and about 6.5 WAR between Danks and Polanco.

06/11 - 07/11 Land New York Mets Tickets staging in PNC Park, Rangers Ballpark In Arlington. New York Mets is staging in Pittsburgh, Arlington and Miami Gardens. New York Mets tickets

04/11 - 05/11 Pick up Detroit Red Wings Tickets staging in Jobing.com Arena, 1st Mariner Arena. Detroit Red Wings is staging in Glendale, Baltimore and Broomfield. Detroit Red Wings tickets

05/11 - 08/11 Pick up Toronto Blue Jays Tickets performing in Safeco Field, Target Field. Toronto Blue Jays is performing in Seattle, Minneapolis and Saint Petersburg. Toronto Blue Jays tickets

The two Baker brought up, Tuiasosopo and Hall, would pretty much be our only options if we were to trade Lopez. It’s still too soon to tell as to whether or not Tui could handle the starting second baseman job, but he’d in all likelihood be slightly below average defensively and end up being about a 0.5-1 WAR player.So, if we were to make the Lopez, Lowe, and Vargas for Danks trade, and then stuck Tui at second base, we’d still be trading about $4 million in 2010 salaries and about five WAR, and we’d end up getting about $3.5 million in 2010 salaries and about 3.5-4 WAR.In that scenario, we’d not only be making the on-field product worse, but we’d also be getting less for our money. So no, trading Jose Lopez and replacing him with Matt Tuiasosopo would not be a good idea at least not with that trade return.As for Hall, he’s had very limited experience at second base, and he hasn’t had any substantial time there since 2004.

That’s way too small of a sample size to really gather anything from, but for the record, he was roughly average defensively in his time there, and that’s what I’d expect from him going into 2010 if he were to end up there.It probably won’t matter though, as I don’t see his offense ever reverting to 2006 form, and there’s virtually no way they take an average defender with a sub .300 wOBA and make him an everyday player.I’d like to think I really got to the bottom of something or came to some sort of conclusion, but it’s still 100 percent speculation, and all of this completely changes if Jose Lopez gets traded as a part of any other deal God, the offseason sucks. You can follow me on Twitter here Or you can visit my Seattle Mariners blog here.. Remember a few years back, Husker fans A few years ago when Nebraska fans thought their football team was on the rise and USC came to townNo, this isn't an article about football. This is a plea for a big win early in the season from a Husker basketball fan. Nebraska looks like they pulled a little something together in games against TCU and UMKC.WhoExactly.ThisSunday, Nebraska is going to play a real team from a real conference. The question Husker fans are asking themselves is: Is this going to be the Husker team that got trounced by St. SANTA CLARA, Calif.(Business Wire)Affymetrix Inc (NASDAQ:AFFX) today announced that Kevin M. To access both the live and archived webcasts, please go to click on the "Investors" link under the "Resources for" dropdown. Anarchived webcast of the presentation will be available for 30 days. About AffymetrixAffymetrix GeneChip microarray technology is the industry-standard tool foranalyzing complex genetic information.

After inventing microarray technology inthe late 1980s, Affymetrix scientists have been dedicated to developinginnovative products that provide researchers with a more complete view of thegenome. These products continue to accelerate genetic research and enablescientists to develop diagnostics and tailor treatments for individual patientsby identifying and measuring the genetic information associated with complexdiseases. Today, Affymetrix technology is used by the worlds top pharmaceutical,diagnostic and biotechnology companies, as well as leading academic, governmentand not-for-profit research institutes. More than 1,800 systems have beenshipped around the world and more than 14,000 peer-reviewed papers have beenpublished using the technology. Affymetrix is headquartered in Santa Clara, Calif., and has manufacturingfacilities in Sacramento, Calif., Cleveland, Ohio, and Singapore. The companyhas about 1,100 employees worldwide and maintains sales and distributionoperations across Europe and Asia.

For more information about Affymetrix, pleasevisit the companys website at Forward-looking StatementsAll statements in this press release that are not historical are"forward-looking statements" within the meaning of Section 21E of the SecuritiesExchange Act as amended, including statements regarding Affymetrix"expectations," "beliefs," "hopes," "intentions," "strategies" or the like. These and other riskfactors are discussed in Affymetrix Form 10-K for the year ended December 31,2007, and other SEC reports, including its Quarterly Reports on Form 10-Q forsubsequent quarterly periods. Affymetrix expressly disclaims any obligation orundertaking to release publicly any updates or revisions to any forward-lookingstatements contained herein to reflect any change in Affymetrix expectationswith regard thereto or any change in events, conditions or circumstances onwhich any such statements are based. NOTE: Affymetrix, the Affymetrix logo and GeneChip are registered trademarksowned or used by Affymetrix Inc. But is everything doom and gloom for this squad, or is there help on the way Is head coach Rich Rodriguez in over his head in the Big Ten, or has he already laid the groundwork for successOn this Thanksgiving Day, as we visit with loved ones, stuff our faces with turkey and pumpkin pie, and watch the Cowboys and Lions, lets take an early look at what the 2010 version of Michigan football will look like. Certainly a lot of questions have to be answered, and I believe it starts with the players Rodriguez already has in the program.